Received Aug 22, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | Y003883 | — |
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | — | — |
No symptoms reported. No additional AE details reported.; Caller reported AE on behalf of a patient who was inadvertently administered an expired dose of PROQUAD on 08/06/2025 (w/ no TEs)-- SUPPORTED via post-expiry memo. No symptoms reported. No additional AE details reported.; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 06-Aug-2025, the patient was inadvertently administered an expired dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) (lot #Y003883, expiration date: 05-Aug-2025) 0.5 mL/dose as prophylaxis (w/ no temperature excursions (TEs)) (Expired product administered). The vaccine was reconstituted with sterile diluent (Hollister-Stier STERILE DILUENT) (lot # and expiration date were not reported). No symptoms reported. No additional adverse event (AE) details reported (No adverse event). This is one of several reports received from the same reporter.